Regulatory News: Median Technologies (FR0011049824, ALMDT, éligible PEA/PME), annonce la date de publication de ses résultats 2024 : Publication...
Regulatory News: Au titre du contrat de liquidité portant sur les actions de la société Median Technologies (FR0011049824, ALMDT, éligible au...
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers. Regulatory News:...
Peer-reviewed scientific e-poster: "Performances of an End-to-End AI/ML CADe/CADx SaMD for Nodule Detection and Characterization in Lung Cancer...
Pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations. Regulatory News: Median Technologies...
Two globally leading pulmonologists reviewed REALITY data, AI and the potential impact on lung cancer screening Replay in English is available...
Webinar to focus on the eyonis™ Lung Cancer Screening (LCS) REALITY data November 7, 2024 – 1:30 pm CET / 7:30 am ET – Registration...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads